ADC Therapeutics
(NYSE:ADCT)
$4.3692
0.1692[4.03%]
At close: Mar 28
$4.3692
0[0.00%]
PreMarket: 9:07AM EDT
Consensus Rating1
Buy
Highest Price Target1
$55.00
Lowest Price Target1
$2.00
Consensus Price Target1
$20.23

ADC Therapeutics Stock (NYSE:ADCT), Analyst Ratings, Price Targets, Predictions

ADC Therapeutics SA has a consensus price target of $20.23, established from looking at the 43 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, RBC Capital, and HC Wainwright & Co. on March 28, 2024, March 14, 2024, and March 6, 2024. With an average price target of $9.33 between Guggenheim, RBC Capital, and HC Wainwright & Co., there's an implied 113.62% upside for ADC Therapeutics SA from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
2
1
Feb
2
Mar
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Guggenheim
RBC Capital
HC Wainwright & Co.
TD Cowen
JP Morgan

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for ADC Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/28/2024ADCTBuy Now
ADC Therapeutics
$4.37151.76%Guggenheim
Michael Schmidt
→ $11Initiates → BuyGet Alert
03/14/2024ADCTBuy Now
ADC Therapeutics
$4.3783.1%RBC Capital
Gregory Renza
→ $8ReiteratesOutperform → OutperformGet Alert
03/06/2024ADCTBuy Now
ADC Therapeutics
$4.37105.99%HC Wainwright & Co.
Robert Burns
→ $9ReiteratesBuy → BuyGet Alert
02/26/2024ADCTBuy Now
ADC Therapeutics
$4.3783.1%RBC Capital
Gregory Renza
$6 → $8MaintainsOutperformGet Alert
02/20/2024ADCTBuy Now
ADC Therapeutics
$4.37105.99%HC Wainwright & Co.
Robert Burns
$3 → $9MaintainsBuyGet Alert
11/20/2023ADCTBuy Now
ADC Therapeutics
$4.37-31.34%HC Wainwright & Co.
Robert Burns
$12 → $3MaintainsBuyGet Alert
11/09/2023ADCTBuy Now
ADC Therapeutics
$4.37TD Cowen
Boris Peaker
DowngradeOutperform → Market PerformGet Alert
11/08/2023ADCTBuy Now
ADC Therapeutics
$4.3737.32%RBC Capital
Gregory Renza
$7 → $6MaintainsOutperformGet Alert
09/19/2023ADCTBuy Now
ADC Therapeutics
$4.37174.65%HC Wainwright & Co.
Robert Burns
→ $12ReiteratesBuy → BuyGet Alert
09/12/2023ADCTBuy Now
ADC Therapeutics
$4.3783.1%RBC Capital
Gregory Renza
$9 → $8MaintainsOutperformGet Alert
08/10/2023ADCTBuy Now
ADC Therapeutics
$4.37JP Morgan
Brian Cheng
UpgradeUnderweight → NeutralGet Alert
08/09/2023ADCTBuy Now
ADC Therapeutics
$4.37105.99%RBC Capital
Gregory Renza
$10 → $9MaintainsOutperformGet Alert
07/25/2023ADCTBuy Now
ADC Therapeutics
$4.37174.65%HC Wainwright & Co.
Robert Burns
→ $12ReiteratesBuy → BuyGet Alert
07/11/2023ADCTBuy Now
ADC Therapeutics
$4.37-54.23%Morgan Stanley
Jeffrey Hung
$5 → $5ReiteratesEqual-Weight → Equal-WeightGet Alert
06/20/2023ADCTBuy Now
ADC Therapeutics
$4.37174.65%HC Wainwright & Co.
Robert Burns
$20 → $12MaintainsBuyGet Alert
05/10/2023ADCTBuy Now
ADC Therapeutics
$4.37128.87%RBC Capital
Gregory Renza
$12 → $10MaintainsOutperformGet Alert
04/24/2023ADCTBuy Now
ADC Therapeutics
$4.37-54.23%B of A Securities
Tazeen Ahmad
$7 → $2DowngradeNeutral → UnderperformGet Alert
02/13/2023ADCTBuy Now
ADC Therapeutics
$4.37174.65%RBC Capital
Gregory Renza
$18 → $12MaintainsOutperformGet Alert
01/24/2023ADCTBuy Now
ADC Therapeutics
$4.3714.44%Morgan Stanley
Matthew Harrison
$7 → $5MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for ADC Therapeutics (ADCT)?

A

The latest price target for ADC Therapeutics (NYSE: ADCT) was reported by Guggenheim on March 28, 2024. The analyst firm set a price target for $11.00 expecting ADCT to rise to within 12 months (a possible 151.76% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ADC Therapeutics (ADCT)?

A

The latest analyst rating for ADC Therapeutics (NYSE: ADCT) was provided by Guggenheim, and ADC Therapeutics initiated their buy rating.

Q

When was the last upgrade for ADC Therapeutics (ADCT)?

A

The last upgrade for ADC Therapeutics SA happened on August 10, 2023 when JP Morgan raised their price target to N/A. JP Morgan previously had an underweight for ADC Therapeutics SA.

Q

When was the last downgrade for ADC Therapeutics (ADCT)?

A

The last downgrade for ADC Therapeutics SA happened on November 9, 2023 when TD Cowen changed their price target from N/A to N/A for ADC Therapeutics SA.

Q

When is the next analyst rating going to be posted or updated for ADC Therapeutics (ADCT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ADC Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ADC Therapeutics was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.

Q

Is the Analyst Rating ADC Therapeutics (ADCT) correct?

A

While ratings are subjective and will change, the latest ADC Therapeutics (ADCT) rating was a initiated with a price target of $0.00 to $11.00. The current price ADC Therapeutics (ADCT) is trading at is $4.37, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.